Please login to the form below

Not currently logged in
Email:
Password:

Phagenesis

This page shows the latest Phagenesis news and features for those working in and with pharma, biotech and healthcare.

Nestlé Health Science invests $145m in food allergy biotech

Nestlé Health Science invests $145m in food allergy biotech

These include Nestlé's $1.9bn partnership on potential inflammatory bowel disease treatments and the acquisition of UK medical device firm and dysphagia specialist Phagenesis..

Latest news

  • Nestlé Health Science buys medical device firm Nestlé Health Science buys medical device firm

    Acquisition of UK's Phagenesis expected to be completed by 2019. Nestlé Health Science is continuing to expand its interests in the broader pharma space with the acquisition of UK medical ... The staged acquisition is expected to close in 2019 but

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics